Title : Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.

Pub. Date : 2010 Nov

PMID : 20939743






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AREAS COVERED IN THIS REVIEW: Preclinical and clinical studies of avanafil, a new oral PDE5 inhibitor being investigated for the treatment of ED. avanafil phosphodiesterase 5A Homo sapiens
2 TAKE HOME MESSAGE: We propose that avanafil, which displays enhanced selectivity, faster onset of action, and a favorable side-effect profile relative to currently available PDE5 inhibitors, may offer an alternative first line treatment option for men with ED. avanafil phosphodiesterase 5A Homo sapiens